Au2Pt-PEG-Ce6 nanoformulation with dual nanozyme activities for synergistic chemodynamic therapy / phototherapy

Man Wang,Mengyu Chang,Qing Chen,Dongmei Wang,Chunxia Li,Zhiyao Hou,Jun Lin,Dayong Jin,Bengang Xing
DOI: https://doi.org/10.1016/j.biomaterials.2020.120093
IF: 14
2020-09-01
Biomaterials
Abstract:<p>Although synergistic therapy for tumors has displayed significant promise for effective treatment of cancer, developing a simple and effective strategy to build a multi-functional nanoplatform is still a huge challenge. By virtue of the characteristics of tumor microenvironment, such as hypoxia, slight acidity and H<sub>2</sub>O<sub>2</sub> overexpression, Au<sub>2</sub>Pt-PEG-Ce6 nanoformulation is constructed for collaborative chemodynamic/phototherapy of tumors. Specifically, the Au<sub>2</sub>Pt nanozymes with multiple functions are synthesized in one step at room temperature. The photosensitizer chlorin e6 (Ce6) is covalently linked to Au<sub>2</sub>Pt nanozymes for photodynamic therapy (PDT). Interestingly, the Au<sub>2</sub>Pt nanozymes possess catalase- and peroxidase-like activities simultaneously, which not only can generate O<sub>2</sub> for relaxation of tumor hypoxia and enhancement of PDT efficiency but also can produce ∙OH for chemodynamic therapy (CDT). In addition, the high photothermal conversion efficiency (<em>η</em> = 31.5%) of Au<sub>2</sub>Pt-PEG-Ce6 nanoformulation provides the possibility for photoacoustic (PA) and photothermal (PT) imaging guided photothermal therapy (PTT). Moreover, the presence of high-Z elements (Au and Pt) in Au<sub>2</sub>Pt-PEG-Ce6 nanoformulation endows it with the ability to act as an X-ray computed tomography (CT) imaging contrast agent. All in all, the Au<sub>2</sub>Pt-PEG-Ce6 exhibits great potential in multimodal imaging-guided synergistic PTT/PDT/CDT with remarkably tumor specificity and enhanced therapy.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?